AstraZeneca’s Durvalumab gets CDSCO nod to treat locally advanced or metastatic biliary tract cancer Read more
Sanofi and IGM Biosciences announce collaboration agreement for oncology, immunology and inflammation targets Read more
Patient access to gene therapies for cancer likely to increase in the next decade: GlobalData Read more
Key unmet needs in HNSCC may be partly addressed by clinical development in next decade: GlobalData Read more
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData Read more